Roth Capital Initiates Solazyme With Buy By: Benzinga via Benzinga November 06, 2014 at 09:01 AM EST Roth Capital initiated coverage on shares of Solazyme (NASDAQ: SZYM) with a Buy rating. The target price for Solazyme is set to $6. ... Read More >>